Marion Noret Selected Research

Hydroxychloroquine (Plaquenil)

12/2021

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marion Noret Research Topics

Disease

3	COVID-19 02/2024 - 07/2021
1	Sepsis (Septicemia) 01/2024
1	Infections 07/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018

Drug/Important Bio-Agent (IBA)

1	tixagevimabIBA 02/2024
1	cilgavimab and tixagevimab drug combinationIBA 02/2024
1	cilgavimabIBA 02/2024
1	Lopinavir FDA Link 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Ritonavir (Norvir)FDA Link 12/2021
1	AerosolsIBA 07/2021
1	CreatinineIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2024
1	Personal Protective Equipment 07/2021